Baue, A. E. (1992). The horror autotoxicus and multiple-organ failure, Arch. Surg.
Baue, A. E. (1998). Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle?, Shock
Baue, A. E., Berlot, A. and Gullo, A. (Eds) (1998). Sepsis and Organ Dysfunction: Epidemiology and Scoring Systems, Pathophysiology and Therapy. Springer Verlag, Milan.
Baird, B. R., Cherionis, J. et al. (1986). Oxygen metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs, J. Appl. Physiol.
Dan, P., Nizan, D. et al.
degrades cell surface proteoglycans and exposes the cells to lysis by Phospholipase A2
: A novel mechanism for cell damage in inflammatory processes, FEBS Letters
Faist, E. and Kim, C. (1998). Therapeutic immunomodulatory approach to control the systemic inflammatory responce syndrome and prevention of sepsis, New Horiz.
6 (Suppl), 97–102.
Ferrante, A., Kowanko, I. C. and Bates, E. J. (1992). Mechanisms of host tissue damage by cytokine-activated neutrophils, in: Granulocyte Responses to Cytokines: Basic Clinical Research, Coffey, R. G. (Ed.), pp. 499–521. Marcel Dekker, New York.
Fisher, C. J. and Zheng, Y. (1996). Potential strategies for inflammatory mediator manipulations: Retrospect and prospect, World J. Surg.
Fujiata, H., Morita, I., Morita I., Ishikawa, K. and Sei-itsu, M. (1996). The synergistic effect of elastase and hydrogen peroxide on vascular endothelial cells. J. Atherosclerosis, Thrombosis
Furies, D. G. (1998). Interferon-therapy for infectious complications of injury, Crit. Care Med.
Gallili, R., Yamin, A., Waksmann, Y., Ovadia, H., Weidenfield, J., Bar, J., Biegon and Mechoulam, R. (1997). Protection against septic shock and suppression of tumor necrosis factor and nitric oxide by dexacabinol (HU-211) a non-psychotropic canabinoid, J. Pharmacol. Exp. Then
Ginsburg, I. (1972). Mechanisms of cell and tissue injury induced by group A streptococci: relation to post-streptococcal sequelae, J. Infect. Dis.
, 294–340, 419-456.PubMed
Ginsburg, I. (1979). The role of lysosomal factors of leukocytes in the biodegradation and storage of microbial constituents in infectious granulomas (a review), Front. Biol.
Ginsburg, I. (1987). Cationic polylectrolytes: A new look into their possible roles as opsonins, as stimulators of the respiratory burst in leukocytes, in bacteriolysis and as modulators of immune complex diseases, Inflammation
Ginsburg, I. (1988). The biochemistry of bacteriolysis: Facts, paradoxes and myths, Microbiol. Sci.
Ginsburg, I.(1989). Bacteriolysis is inhibited by hydrogen peroxide and proteases, Agents Actions
Ginsburg, I. (1994). Can hemolytic streptococci be considered “forefathers” of modern phagocytes? Both cell types freely migrate in tissues and destroy host cells by a “synergistic cross-talk” among their secreted agonists, Comp. Biochem. Physiol.
Ginsburg, I. and Kohen, R. (invited Review) (1995). Cell damage in inflammatory and infectious sites might involve a coordinated “cross-talk” among oxidants, microbial hemolysins and amphiphiles, cationic proteins, phospholipases, fatty acids, proteinases and cytokines (an overview), Free Rad. Res.
Ginsburg, I. (1998). Could synergistic interactions among reactive oxygen species, proteinases, membrane-perforating enzymes, hydrolases, microbial hemolysins and cytokines be the main cause of tissue damage in infectious and inflammatory conditions?, Medical Hypothesis
Ginsburg, I. and Barak, To be published.
Ginsburg, I. and Sadovnic, M. (1998). Gamma globulin, Evan’s blue, aprotinin, tetracycline and antioxidants protect epithelial cells against damage induced by synergism among streptococcal hemolysins, oxidants and proteinases: relation to the prevention of septic shock, FEMS Immunol. Med. Microbiol.
Ginsburg, I., Sadovnic, M., Sallon, S., Milo-Goldzweig, I., Mechoulam, R., Breurer, A., Gibbs, D.F., Varani, J., Roberts, S., Cleator, E. and Singh, N. (1999). PADMA-28, a traditional Tibetan herbal preparation inhibits the respiratory burst in human neutrophils, the killing of epithelial cells by mixtures of oxidants, and pro-inflammatory agonists and peroxidation of lipids, Inflammopharmacology
Ginsburg, I., Ward, P. A. and Varani, J. (1999). Can we learn from the pathogenetic properties of group A hemolytic streptococci how tissues are destroyed and organs fail in post-infectious and inflammatory sequelae?, FEMS Immunol. Med. Microbiol.
Hack, C. E. E., Aarden, L. A. and Thijt, L. G. (1997). Role of cytokines in sepsis, Adv. Immunol.
Holzheimer, R. G. (1998). The significance of endotoxin release in experimental and clinical sepsis, in surgical patients: evidence for antibiotic-induced endotoxin release?, Infection
Horn, D. L., Opal, S. M. and Lomastro, E. (1996). Antibiotics, cytokines, and endotoxin: a complex and evolved relationship in Gram-negative sepsis, Scand. J. Infect. Dis.
101 (Suppl. 1), 19–13.
Kiriyama, T., Mityake, Y., Kobayshi, K., Yoshiga, K., Takada, K. and Suginaka, H. (1987). Effects of mucopolysaccharides on penicillin-induced lysis of Staphylococcus aureus, J. Med. Microbiol.
Klebanoff, S. F., Kinsella, M. G. and Wight, T. N. (1983). Degradation of endothelial matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2 -chloride system, Am. J. Physiol.
Lichtenstein, A. K., Ganz, T., Selsted, M. and Lehrer, R. I. (1988). Cytolysis mediated by hydrogen peroxide combined with peptide defensins, Cellular Immunology
Liu, M. and Slutzki, A. S. (1997). Anti-inflammatory therapies: application of molecular biology techniques in intensive care medicine, Intensive Care Med.
Luckacks, N. W. and Ward, P. A. (1996). Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury, Adv. Immunol.
McGowan, S. E. and Murry, J. J. (1987). Direct effect of neutrophil oxidants and elastase-induced extra-cellular matrix proteolysis, Am. Rev. Resp. Dis.
Mendis, A. H. W., Venaille, T. J. and Roobinson, T. N. (1990). Study of human epithelial cell detachment and damage: effect of protease and oxidants, Immunol. Cell Biol.
Nasraway, S. A. (1999). Sepsis research; We must change course, Crit. Care Med.
Natanson, C. (1997). Anti-inflammatory therapies to treat septic shock: A reassessment, Editorial, Crit. Care Med.
Opal, S. M. and Liu, R. L. Jr. (1998). Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions, Drugs
Periti, A. and Mazzeti, A. (1998). Antibiotic-induced release of bacterial cell-wall components in the pathogenesis of sepsis and septic chock: a review, J. Chemother.
Pinsky, M. R. (1996). Organ-specific therapy in critical illness: interfacing molecular mechanisms with physiological interventions, J. Crit. Care
Ralston, D. R. and St. John, R. C. (1996). Immunotherapy for sepsis, Clinics in Chest Medicine
Rice-Evans, C. A. and Diplock, A. T. (1993). Current status of antioxidant therapy, Free Rad. Biol. Med.
Rodell, T. C., Cherionis, J. C., Ohnemous, J. C., Pirmatei, D. J. and Repine, J. E. (1987). Xanthine oxidase-derived toxic oxygen metabolites contribute to lung injury from neutrophil elastase, Chest
Sallon, S. and Beer, G. (1998). The efficacy of PADMA-28, a herbal preparation, in the treatment of intermittent claudication: a controlled double-blind polot study with objective assessment of chronic occlusive arterial disease patients, J. Vasc. Invest.
Schlag, G. and Redl, H. (Eds) (1999). Shock, Sepsis and Organ Failure-Scavenging of Nitric Oxide and Inhibition of its Products. Springer-Verlag, Berlin.
Servansky, J. E., Snaked, G., Novogrodzli, A. and Levitzki, A. (1997). Tyrosine AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli
peritonitis, J. Clin. Invest.
Stevens, D. L. (1995). Streptococcal toxic-shock syndrome: spectrum of diseases, pathogenesis and new concepts of treatment, Emerg. Infect. Dis.
Triujillo, M. H., Guerrero, J., Fragachan, C. and Fernandez, M. A. (1998). Pharmacological antidotes in clinical care medicine: a practical guide for drug administration, Clin. Care Med.
Tuomanen, E. and Tomasz, A. (1984). Protection by D-amino acids against growth inhibition and lysis caused by beta-lactam antibiotics, Antimicrobial Agents Chemother.
Verhoef, J., Hustinx, W. M. N. et al.
(1996). Issues in the adjunct therapy of severe sepsis, J. Antimicrobial Chemother.
Vincent, J. L. (1997). Clinical trials in sepsis: Where do we stand?, J. Crit. Care
Wecke, J., Kwa, E., Lahav, M. and Ginsburg, I. (1987). Suppression of penicillin-induced bacteriolysis of staphylococci by some anticoagulants, J. Antimicrob. Chemother.
Wecke, J., Franz M. and Giesbrecht, P. (1990). Inhibition of the bacteriolytic effect of beta-lactam antibiotics on Staphylococcus aureus by the polyanionic drugs suramine and Evans’ blue, AMPIS
Weiss, S. (1989). Tissue destruction by neutrophils, New Engl. J. Med.
Weiss, D. J., Curnutte, J. T. and Regiant, S. (1986). Neutrophil-mediated solubilization of subendothelial matrix: oxidative and non-oxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes, J. Immunol.
Wheeler, A. P. and Bernard, G. R. (1996). Application of molecular biology and biotechnology: antibody therapy of sepsis, J. Crit. Care
Wheeler, A. P. and Bernard, G. R. (1999). Treating patients with severe sepsis, New Engl. J. Med.
Yao, Y. M., Redl, H. and Schlag, G. (1998). The inflammatory basis of trauma/shock-associated multiple organ failure, Inflamm. Res.
Zanetti, G. and Glauser, M. P. (1997). Prevention and treatment of sepsis and septic shock, Curr. Opnion. Infect. Dis.